Event Overview

From Code to Care: Combating Business Crime in Healthcare Today

Set in the breathtaking city of Florence, this seminar brings together experts, innovators, and leaders to explore the intersection of business crime, and healthcare. In an increasingly digital world, cutting-edge technologies are revolutionising healthcare systems, and at the same time creating new avenues for criminal conduct. From cyberattacks and data breaches to invoice fraud, product fraud and unethical practices, business crime in healthcare is a growing concern. This seminar aims to provide in-depth discussions on how healthcare organisations can protect themselves against these threats while maintaining trust and quality of care.

With a focus on the latest trends in regulatory frameworks, ethical considerations, and technological security, attendees will gain valuable insight on how to protect sensitive patient data, ensure compliance, and create a safer healthcare environment. Through expert panels, case studies, and interactive sessions, participants will explore the complex challenges for healthcare and life sciences sectors posed by the evolving landscape of business crime. By fostering collaboration between healthcare providers, technology experts, and law enforcement, this conference will offer practical solutions for safeguarding the future of healthcare in an era of constant technological advancement. Attendees will leave the conference equipped with practical tools and insight to help protect actors in the life sciences sector from digital and real-world criminal challenges, all while enjoying the charm and cultural richness of one of Europe’s most iconic cities.

 

AIJA Commissions involved
  • Business Crime and Civil Fraud
  • Healthcare and Life Sciences

Programme

From Code to Care: Combating Business Crime in Today's Innovative and Traditional Healthcare Sector

17:30

18:00 - 21:00

09:00 - 09:30

09:30 - 10:00

10:00 - 11:00

This panel will explore the challenge of corruption within healthcare systems, including issues like bribery, bid rigging, fraudulent contract awarding, and conflicts of interest. Experts will discuss strategies for mitigating these risks, focusing on transparent practices (including in public procurement), regulatory oversight, and the use of technology in promoting accountability. The discussion will also cover the broader impact of corruption on healthcare delivery, patient care, and overall costs, emphasizing the importance of ethical conduct among healthcare professionals at all levels, as well as real-life examples of how criminal litigation has been tackled in similar matters.
11:00 - 11:30

11:30 - 12:30

This discussion will focus on innovative technological solutions like artificial intelligence, blockchain, and machine learning, which are being used to detect fraudulent billing, identity theft, and other fraudulent activities. Panelists will also highlight how data analytics can improve the accuracy of fraud detection in healthcare.
12:30 - 13:30

13:30 - 14:30

With healthcare systems storing vast amounts of sensitive personal data, the threat of data breaches is a growing concern. This panel will delve into the risks of cyberattacks and the methods criminals use to exploit vulnerabilities in healthcare IT infrastructure. Experts will examine the steps healthcare organizations can take to safeguard patient information and respond to data breaches, as well as the legal and ethical implications of privacy violations (including how to deal with doctor’s privileged information in a criminal investigation). Additionally, the rise of telemedicine has introduced new avenues for fraud, including fake appointments, fraudulent claims, and misrepresentation of services. Panelists will examine the regulatory challenges, best practices for telemedicine providers, and technologies that can help identify and prevent fraud in virtual healthcare settings."
14:30 - 15:00

15:00 - 16:00

As innovation accelerates in healthcare, so do the risks associated with product liability and fraud. This panel will explore the legal, ethical, and operational challenges surrounding defective or misrepresented medical products, from pharmaceuticals to devices. Experts will discuss how fraudulent practices - such as data manipulation, off-label marketing, and failure to disclose risks - can endanger patient safety and erode public trust. Panelists will examine recent high-profile cases, enforcement trends, and the role of whistleblowers, regulators, and internal compliance in detecting and preventing misconduct. The session will highlight proactive strategies for healthcare organizations to manage risk, ensure transparency, and uphold accountability across the product lifecycle.
19:00 - 23:00

09:30

10:00 - 11:00

Healthcare markets can sometimes fall victim to anti-competitive behaviors like collusion and price-fixing, leading to inflated costs for patients and insurers (including issues related to vertical agreements imposed by the pharmaceutical companies that create not only antitrust issues but may lead to potentially fraudulent activities of the wholesaler if they do not comply with the contractual restrictions). This panel will explore the role of antitrust law in combating these practices, with a focus on recent cases and regulatory actions aimed at ensuring fair competition in the healthcare sector. Experts will also discuss the implications of consolidation in the healthcare industry and the potential for monopolistic behavior.
11:00 - 11:30

11:30 - 12:30

This panel will examine the intersection of corporate social responsibility (CSR) and ethical dilemmas in the healthcare industry, focusing on how organizations can align business practices with patient care and public trust. Panelists will explore how CSR frameworks - including environmental, social, and governance (ESG) considerations - can help healthcare companies prevent business abuse, while promoting transparency, accountability, and long-term community benefit. The discussion will also address the ethical challenges of balancing profitability with patient well-being, such as misleading marketing, overcharging, unnecessary treatments, and premature drug access. Through real-world case studies and expert insights, attendees will learn how to navigate conflicts of interest, prioritize ethical decision-making, and implement responsible business strategies that protect patients while maintaining financial integrity.
12:30 - 14:00

Fees & General Info

There are currently no registration fees available.

General terms and conditions

By registering you have to accept the general terms and conditions and accept that your registration is considered binding immediately, but participation to the event is possible only after full payment of the registration fee.

Please note that any arrangements related to the participation of the participant in an AIJA event, including but not limited to booking or cancellation of accommodation or flights, as well as respecting the cancellation deadlines indicated in the general terms and conditions, are the sole responsibility of the participant. AIJA shall not be held liable for any expenses the participant may suffer as the result of participant’s failure to comply with his/her obligations.

It is recommended for each participant to purchase a cancellation and travel insurance.

Please note that in-house counsel registrations are subject to review and confirmation by AIJA. AIJA considers in-house counsel professionals who hold a university degree in law allowing access to a bar association and practicing law as an in-house counsel in private, public, or non-profit companies, institutions or organisations. Please note that in-house counsel who are at the same time active as fee-earning lawyers or consultants are not eligible to the discounted in-house counsel fee.

Please read the general terms and conditions applicable for AIJA events.

Scholarships

If you are a lawyer under 35 years old and meet the requirements, apply to our Scholarship Programme for this event. You can check more details here.

Organising Committee

Davide ALEMANNI
Davide ALEMANNI Gianni & Origoni (ITALY)
Alois BLIN
Alois BLIN TALMA AVOCATS (FRANCE)
Edoardo DIPPOLITO
Edoardo DIPPOLITO Cocuzza & Associati (ITALY)
Paco GARCÍA
Paco GARCÍA Uría Menéndez Abogados, S.L..P. (SPAIN)
Margherita PALA
Margherita PALA Margherita Pala (ITALY)
Thomas RICARD
Thomas RICARD JP Karsenty & Associés (FRANCE)
Daria RUTECKA
Daria RUTECKA Schoenherr Halwa Okoń Chyb sp.k. (POLAND)
Neli SOCHIRCA
Neli SOCHIRCA PRODENMART (FRANCE)

Sponsors

Become a sponsor

Partnership with AIJA as a sponsor provides the best networking opportunities in a relaxed business environment.
If you have any questions, contact us on ‘Become a sponsor’ and check for more opportunities.

Become a sponsor More about sponsorship

Personal Protection

The personal data that you communicate to us shall be processed by the International Association Of Young Lawyers (AIJA), with its registered office at Avenue de Tervueren 231, 1150 Brussels, Belgium (Tel: +32 2 347 33 34 - office@aija.com), in accordance with Act No. 78-17 of January 6, 1978 relating to data, files and freedoms and Regulation No. 2016/679 on data protection, as of its entry into force on May 25, 2018.

Your data will be managed by AIJA's General Services, Events and Accounts Section:

  • For the purpose of administering your registration for the event and your on-site access to the event;
  • In order to pay for the selected services - your bank details will be deleted after receipt of your payment;
  • In order to communicate information messages from AIJA.

To the extent necessary for the execution of their respective tasks, our subcontractors in charge of our seminar organisation, our IT infrastructure, our management, the production and maintenance of our website and extranet, are likely to gain access to your data from time to time. Their servers are located in the European Union.

Data relating to your participation in the event shall be stored for a period of 10 years. We are obliged to archive billing data until the end of the period required for our tax and accounting obligations, i.e. for 7 full tax years.

We shall store your contact information to keep you informed until you ask us to stop. You have the right to access your data and have it corrected if necessary.